• 2 ASX tech shares I think the market is underestimating

    Woman and AI robot working together in the office.

    Sharp share price falls can sometimes distract from what is still happening inside the business.

    That is how I currently see these two ASX tech shares.

    Both have fallen heavily from their 52-week highs, but I think the market may be overlooking the longer-term growth still ahead.

    Catapult Sports Ltd (ASX: CAT)

    Catapult shares are trading around $3.12 on Friday, roughly 60% below their 52-week high of $7.72.

    The company provides performance technology used by professional sporting organisations to analyse athletes, training loads, video, and other performance data.

    What I like is that Catapult operates in a relatively specialised market where its products can become part of the everyday workflow of coaches, analysts, and performance staff.

    That creates an opportunity to grow alongside customers rather than relying entirely on constantly finding new ones.

    I also think the ASX tech share has a long runway because professional sport is becoming increasingly data-driven. Teams are spending more on analytics, performance monitoring, and technology that can help improve decision-making.

    If Catapult can continue to deepen its relationships with major sporting organisations, I think the business could look considerably larger several years from now.

    At $3.12, I think the market may be underestimating that potential.

    SiteMinder Ltd (ASX: SDR)

    SiteMinder is an ASX tech share that has fallen even further, trading around $2.60 compared with a 52-week high of $7.96.

    The company provides technology that helps hotels manage how their rooms are sold across different online channels.

    I like the scale of the problem SiteMinder is trying to solve.

    Hotels increasingly need to manage bookings across their own websites, online travel agencies, and other distribution channels. Doing that efficiently becomes more complicated as the number of channels grows.

    SiteMinder sits in the middle of that process, giving hotels technology to manage distribution, pricing, and bookings more efficiently.

    I think the market may be overlooking how much room there still is for hotel technology to modernise.

    A large part of the accommodation industry remains fragmented, with independent hotels and smaller operators still moving more of their operations online. That creates a sizeable addressable market for a platform that can simplify those processes.

    The recent share price performance has clearly been disappointing, but I would separate that from the longer-term opportunity.

    If SiteMinder can keep expanding its customer base and generate more revenue from each hotel using its platform, I think today’s share price could prove to be a very attractive entry point.

    Foolish takeaway

    Catapult and SiteMinder are very different businesses, but I think the market may be making the same mistake with both.

    Their share prices have fallen sharply, yet each still has exposure to an industry becoming more reliant on technology.

    If both ASX tech shares keep executing and their markets continue moving in their favour, I think today’s prices could prove to be great value.

    The post 2 ASX tech shares I think the market is underestimating appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Catapult Sports right now?

    Before you buy Catapult Sports shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Catapult Sports wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool Australia has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 5 best ASX shares to buy in October

    Two shop workers smiling and looking at a laptop surrounded by plants.

    October is almost here, which means investors may be thinking about where to put fresh money to work next month.

    For me, some of the best opportunities on the ASX are shares with strong competitive positions and plenty of room to keep growing over the long term.

    If I were building a shopping list for October, these five ASX shares would be near the top.

    ResMed Inc. (ASX: RMD)

    ResMed is one of my favourite healthcare shares on the ASX.

    The company is a global leader in devices and masks used to treat sleep apnoea, giving it exposure to a large healthcare market with recurring demand.

    One thing I like is the repeat-purchase element of the business. Patients need replacement masks and other accessories over time, providing ResMed with an ongoing relationship beyond the initial device sale.

    With a huge global market and a strong position in sleep and respiratory care, I think ResMed has plenty of room to keep compounding earnings over the long term.

    Pro Medicus Ltd (ASX: PME)

    Pro Medicus is another ASX share I would be happy to buy for the long term.

    Its Visage imaging software has become an important part of the technology infrastructure used by major healthcare organisations, particularly in the United States.

    What I like is the combination of a highly scalable software model and exposure to growing demand for medical imaging.

    As hospitals generate more scans and look for faster, more efficient ways to manage them, I think Pro Medicus remains well placed to benefit.

    The shares can command a high valuation, but the quality and growth potential of the business keep it on my buy list.

    Life360 Inc (ASX: 360)

    Life360 gives investors a very different type of growth opportunity.

    The company operates a family location and safety platform used by millions of people around the world.

    It has been growing rapidly for years, but I believe this can continue. Subscription growth, international expansion, and new services could all help Life360 become a much larger business.

    There will probably be plenty of volatility along the way, but for investors with a long horizon, I think the growth runway remains attractive.

    Xero Ltd (ASX: XRO)

    Xero is another ASX technology share I would buy in October.

    Its accounting software is deeply embedded in the day-to-day operations of small businesses, accountants, and bookkeepers.

    But it is still only scratching at the surface of its large international opportunity.

    As more small businesses move their financial processes online, I think the company can continue growing its customer base and generating more revenue from existing users with extra services.

    WiseTech Global Ltd (ASX: WTC)

    WiseTech is my final pick for October.

    Its CargoWise platform helps freight forwarders and logistics companies manage complex global supply chains.

    I like how deeply the software can become embedded in customer operations, which can make it difficult to replace and gives WiseTech a strong base for recurring growth.

    The company also has a large international opportunity as logistics businesses continue investing in automation and more efficient supply chain management.

    For me, that combination makes WiseTech one of the ASX technology shares I would be happy to buy for the long term.

    Foolish takeaway

    If I were putting new money into the ASX in October, these are the sorts of businesses I would want to own.

    ResMed and Pro Medicus give me exposure to healthcare growth, while Life360, Xero, and WiseTech provide different ways to participate in the continued expansion of global technology businesses.

    I would be comfortable buying all five with the intention of holding them for many years.

    The post 5 best ASX shares to buy in October appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Life360 right now?

    Before you buy Life360 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, ResMed, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Soul Patts vs Macquarie Group: Best ASX dividend stock for retirees?

    Hand putting coins in a glass jar that says retirement, with a retro alarm clock on the other side, and piles of increasing coins in the middle.

    Washington H Soul Pattinson vs Macquarie Group shares: Which dividend stock suits retirees best?

    If you’re a retiree thinking about income and stability, two blue-chip ASX names might be sitting on your shortlist: Washington H Soul Pattinson and Co Ltd (ASX: SOL) and Macquarie Group Ltd (ASX: MQG). They’re both stalwarts, well-regarded for diversified holdings and consistent dividends—but which one really deserves a place in a retiree’s portfolio? Here’s how they compare on yield, franking, and all-important reliability.

    The case for Washington H Soul Pattinson and Co

    Washington H Soul Pattinson—often known as Soul Patts—has its roots in Australian pharmacy, but these days is best described as a diversified investment house. Over its long history (listed since 1903), Soul Patts has built a portfolio spanning listed and private companies, real assets, and emerging ventures. Some of its largest stakes, according to its most recent public description, are in TPG Telecom and New Hope Corporation. The 2025 merger with Brickworks has also made Brickworks a subsidiary under the Soul Patts umbrella.

    From a fundamentals viewpoint, several things stand out. Soul Patts has a market cap of $17.29 billion and sports a price-to-earnings (P/E) ratio of 7.08, which is much lower than Macquarie’s. The dividend yield clocks in at 2.36%, but perhaps most attractive for retirees, dividends come fully franked—at a rate of 100%. That means shareholders can potentially claim the full benefit of franking credits. Soul Patts has a long streak of consistently increasing dividends, rarely missing an opportunity to reward shareholders with reliable, tax-effective income.

    The case for Macquarie Group

    Macquarie Group is one of Australia’s financial powerhouses, providing banking, funds management, advisory, and investment services in more than 30 countries. While technically a bank, Macquarie differs from the “big four,” with much of its money made from asset management, infrastructure, and investment banking rather than traditional retail banking.

    Looking at the numbers, Macquarie is a much larger company, with a $92.97 billion market cap and a significantly higher P/E ratio of 19.12. The dividend yield is a touch higher at 2.89%. A big plus is the generous dollar amount per share—for this year, $7.00 per share in dividends. However, only 35% of those dividends are franked, which means Australian retirees won’t get the maximum tax benefit from those payments. Macquarie’s size and global reputation add a layer of strength, and its dividends tend to be relatively predictable, but they may be less tax-effective compared to Soul Patts.

    Valuation comparison

    Here’s how the two stack up side-by-side on key metrics:

    Metric Washington H Soul Pattinson Macquarie Group
    Market Cap $17.29 billion $92.97 billion
    P/E Ratio 7.08 19.12
    Dividend Yield 2.36% 2.89%
    Earnings per share (EPS) 6.417 12.669
    Dividend per share $0.96 $7.00
    Franking 100% 35%

    Note: Dividend yields are relatively close, but Macquarie’s dividends are only partially franked, while Soul Patts offers fully franked dividends—often a priority for income-focused investors. It’s also notable that Soul Patts’ P/E suggests a much lower valuation relative to current earnings. If you notice the gap between EPS and P/E, keep in mind that reported P/E ratios may sometimes be based on underlying or future earnings rather than trailing or statutory EPS, which can create apparent inconsistencies.

    Recent share price performance

    Let’s consider recent share price action (up until 23 September):

    • Washington H Soul Pattinson closed at $45.51 on 23 Sept 2026, up slightly by 0.2% from the previous day.
    • Year-to-date return for SOL shares sits at 23.6%—a strong showing.
    • Macquarie Group closed at $242.35 on 23 Sept 2026, barely changed from the day prior (+0.03%).
    • Year-to-date return for MQG shares is 21.3%, also very healthy.

    That’s robust price momentum for both, with Soul Patts very slightly ahead on total return as of the latest figures.

    Which is the better buy?

    For my money, if I were a retiree primarily after dividends, my pick would be Washington H Soul Pattinson. Here’s why: even though its headline yield is a tad lower than Macquarie’s, Soul Patts’ commitment to 100% franking maximises the after-tax cash flow for most Australian retirees, especially those who can use franking credits to reduce or eliminate tax. Soul Patts also carries a much lower P/E ratio, which suggests either a lower price relative to earnings or simply a market expectation of steadier but less spectacular growth. Its history of consistent—and growing—dividends gives me extra confidence for dependable income.

    That’s not to say Macquarie isn’t impressive; it’s a massive institution offering higher absolute dividend dollars, a slightly higher yield, and global stability. However, the lower franking cuts into the tax advantage, which is often a make-or-break factor in retirement income streams. Both are excellent businesses, but for franked, tax-effective dividends and reliable track record, I’d lean towards Washington H Soul Pattinson in a retiree-focused portfolio.

    The post Soul Patts vs Macquarie Group: Best ASX dividend stock for retirees? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Washington H. Soul Pattinson and Company Limited right now?

    Before you buy Washington H. Soul Pattinson and Company Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Washington H. Soul Pattinson and Company Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial draft. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Sorry, but nothing was found. Please try a search with different keywords.